volume 157, issue 3, P1182-1192.e1 2019
DOI: 10.1016/j.jtcvs.2018.09.140
View full text
|
|
Share

Abstract: Objectives: We conducted a prospective randomized controlled trial to compare del Nido (DN) and histidine-tryptophan-ketoglutarate (HTK) cardioplegia solution in pediatric patients undergoing intracardiac tetralogy of Fallot repair.Methods: One hundred consecutive patients 12 years of age or younger, undergoing intracardiac repair of tetralogy of Fallot were randomized into DN (n ¼ 50) and HTK (n ¼ 50) groups. Cardioplegia strategy consisted of a single dose of DN (20 mL/kg) or HTK (6 mL/kg/min for 6 minutes).…

expand abstract